With a dozen approvals for biosimilars under its belt already, the Food and Drug Administration has started a new effort to accelerate the development and adoption of the drugs.
{iframe}https://medcitynews.com/2018/07/fda-releases-biosimilars-action-plan-aiming-to-accelerate-innovation/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_source=hs_email&utm_medium=email&utm_content=64672115&_hsenc=p2ANqtz-9PxFupYnpgVHNPK4tNKn3fc5cg5uzdzrJdm1i1vTUTwQ9rGBLRloUGX5Z1MwqVmYcPMG4FmyYQhCz2p-G-xFZi2NOd0Q&_hsmi=64672115{/iframe}